Lipocine Inc

NASDAQ:LPCN 4:00:00 PM EDT

3.98

+0.24 (+6.42%)

4:02:40 PM EDT: $4.18 +0.20 (+5.03%)

Market Cap (Intraday)	21.29M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.16 Million
Adjusted EPS	-$0.38

See more estimates

10-Day MA	$3.80
50-Day MA	$5.07
200-Day MA	$4.79

See more pivots

Lipocine Inc Stock, NASDAQ:LPCN

675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108

United States of America

Phone: +1.801.994.7383

Number of Employees: 17

http://www.lipocine.com

Description

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.